Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ploug

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Frontiers in Nuclear Medicine|October 2, 2024
Optimization and Evaluation of Al<sup>18</sup>F Labeling Using a NOTA-or RESCA1-Conjugated AE105 Peptide Antagonist of uPARTroels E Jeppesen, Marina Simón, Josephine Torp, et al.
Biochemistry|February 6, 2009
Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangementsGrant E Blouse, Daniel M Dupont, Christine R Schar, et al.
Blood|May 15, 2010
Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammationBrian M Connolly, Eun Young Choi, Henrik Gårdsvoll, et al.
Plos One|March 21, 2015
Protein-binding RNA aptamers affect molecular interactions distantly from their binding sitesDaniel M Dupont, Cathrine K Thuesen, Kenneth A Bøtkjær, et al.
Journal of Lipid Research|September 19, 2020
Chylomicronemia from GPIHBP1 autoantibodiesKazuya Miyashita, Jens Lutz, Lisa C Hudgins, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2024
CL-11 circulates in serum as functionally distinct isoformsAdrian Sutta, Nelia Nina Leemans, Michael Ploug, et al.
Molecular Cancer Research : MCR|October 6, 2012
Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanismKenneth A Botkjaer, Elena I Deryugina, Daniel M Dupont, et al.
The Journal of Biological Chemistry|June 27, 2012
Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domainsRené Bager, Thomas K Kristensen, Jan K Jensen, et al.
The EMBO Journal|June 10, 2006
Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient miceLeif R Lund, Kirsty A Green, Allart A Stoop, et al.
Microorganisms|July 15, 2020
<i>Helicobacter pylori</i> Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early PathogenesisWarner Alpízar-Alpízar, Mette E Skindersoe, Lone Rasmussen, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Frontiers in Nuclear Medicine|October 2, 2024
Optimization and Evaluation of Al<sup>18</sup>F Labeling Using a NOTA-or RESCA1-Conjugated AE105 Peptide Antagonist of uPARTroels E Jeppesen, Marina Simón, Josephine Torp, et al.
Biochemistry|February 6, 2009
Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangementsGrant E Blouse, Daniel M Dupont, Christine R Schar, et al.
Blood|May 15, 2010
Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammationBrian M Connolly, Eun Young Choi, Henrik Gårdsvoll, et al.
Plos One|March 21, 2015
Protein-binding RNA aptamers affect molecular interactions distantly from their binding sitesDaniel M Dupont, Cathrine K Thuesen, Kenneth A Bøtkjær, et al.
Journal of Lipid Research|September 19, 2020
Chylomicronemia from GPIHBP1 autoantibodiesKazuya Miyashita, Jens Lutz, Lisa C Hudgins, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 11, 2024
CL-11 circulates in serum as functionally distinct isoformsAdrian Sutta, Nelia Nina Leemans, Michael Ploug, et al.
Molecular Cancer Research : MCR|October 6, 2012
Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanismKenneth A Botkjaer, Elena I Deryugina, Daniel M Dupont, et al.
The Journal of Biological Chemistry|June 27, 2012
Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domainsRené Bager, Thomas K Kristensen, Jan K Jensen, et al.
The EMBO Journal|June 10, 2006
Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient miceLeif R Lund, Kirsty A Green, Allart A Stoop, et al.
Microorganisms|July 15, 2020
<i>Helicobacter pylori</i> Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early PathogenesisWarner Alpízar-Alpízar, Mette E Skindersoe, Lone Rasmussen, et al.
Pageof 13